Cannabis testing involves quantification of major chemical compound and active ingredient in the given specimen of cannabis. Cannabinoids and terpene are major active ingredient that has medicinal potency. Depending on the concentration of the chemical active ingredient, the potency of the sample representing huge quantity of cannabis is decided. Cannabis testing is performed with the help of analytical instruments such as liquid chromatography, gas chromatography etc. Commercial labs offers dedicated cannabis testing services in developed region. Increasing number of the medicinal usage is propelling demand for commercial manufacturing of cannabis. However, government authorities demands quality testing of the cannabis before using them for recreational and medicinal purpose

Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/170

Market Dynamics

Cannabis testing products and services market is witnessing significant growth with increased government approval and loosening regulatory stringent ness over use of cannabis for commercial and recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis plant in the region, which in turn would also drive growth of the cannabis testing market. Furthermore, the Australian government in January 2018, announced that it would allow medicinal cannabis exports, which is expected to provide growth opportunities for domestic manufacturers. Increasing number of laboratories offering cannabis testing is expected to further drive the market growth.

Increased approval for cannabis-based drugs and new product launches for cannabis testing are expected to propel growth of the cannabis testing market

Various cannabis manufacturer across globe are focused on introducing the cannabis products to target various disease, which in turn is expected to promote application of cannabis testing instruments, as this products need to be approved from the health regulatory bodies for their efficacy and purity. For instance, in May 2018, the U.S Food and Drug Administration (FDA) approved the medication, called Epidiolex manufactured by GW Pharmaceuticals to treat two rare forms of epilepsy caused by Lennox-Gastaut and Dravet syndromes in patients two years and older.

Key players operating in the cannabis testing market include Shimadzu Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Millipore Sigma, AB SCIEX LLC, Cannabix Technologies, Inc., Waters Corporation, Steep Hill Labs, Inc., CannaSafe Analytics, Accelerated Technology Laboratories, Inc., LabLynx, Inc., SC Laboratories Inc., GenTech Scientific, Pharm Labs, LLC, and Digipath Labs, Inc.

Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/170

Detailed Segmentation:
• Global Cannabis Testing Market, By Product and Service Type:
◦ Product type
▪ Analytical Instruments
• Chromatography Instruments
◦ Liquid Chromatography
◦ Gas Chromatography
◦ Others
• Spectroscopy Instruments
◦ Mass Spectroscopy
◦ Atomic Spectroscopy
▪ Consumables
▪ Breathe Analyzer
◦ Service Type
▪ Potency Testing
▪ Terpene Testing
▪ Pesticide Testing
▪ Residual Solvent
▪ Heavy Metal Testing
▪ Mycotoxin and Microbial Testing
▪ Others
• Global Cannabis Testing Market, By End Users:
◦ Testing Laboratories
◦ Drug Manufacturer
◦ Research Institutes
• Global Cannabis Testing Market, By Geography:
◦ North America
◦ Latin America
◦ Europe
◦ Asia Pacific
◦ Middle East
◦ Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]